{
    "Relevant Biomarkers": [
        {
            "BioMarker": "PD-L1(SP142)",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Positive| 3+, 23%"
        },
        {
            "BioMarker": "PR",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 2+, 2%"
        },
        {
            "BioMarker": "AR",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 3+, 58%"
        },
        {
            "BioMarker": "AR",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Positive| 1+, 31%"
        },
        {
            "BioMarker": "Mismatch repair status",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 2+, 2%"
        },
        {
            "BioMarker": "CALR",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Mutation not detected"
        },
        {
            "BioMarker": "MPL",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Fusion not detected"
        },
        {
            "BioMarker": "SRSF2",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "FGFR4",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Fusion not detected"
        }
    ],
    "Genomic Signatures": [
        {
            "BioMarker": "Microsatellite instability",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "Equivocal"
        },
        {
            "BioMarker": "Tumor mutational burden",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "16 mutations/Mb High"
        },
        {
            "BioMarker": "Genomic loss of heterozygosity (LOH)",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "High - 32% of tested genmoic segments exhibit LOH"
        }
    ],
    "Genes Tested with Pathogenic Alterations": [
        {
            "Gene": "MTOR",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.Y1225X",
            "Exon": 16,
            "DNA Alteration": "c.5438A>G",
            "Allele Frequency %": "27.82"
        },
        {
            "Gene": "PKLR",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Pathogenic",
            "Protien Alteration": "p.M1R",
            "Exon": 4,
            "DNA Alteration": "c.2T>G",
            "Allele Frequency %": "3.93"
        },
        {
            "Gene": "CALR",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Pathogenic",
            "Protien Alteration": "p.F1888L",
            "Exon": 18,
            "DNA Alteration": "c.5664C>G",
            "Allele Frequency %": "8.06"
        },
        {
            "Gene": "CALR",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Benign",
            "Protien Alteration": "p.K656E",
            "Exon": 14,
            "DNA Alteration": "c.1966A>G",
            "Allele Frequency %": "6.45"
        }
    ]
}